المؤلفين: Heba Salema, Mahmoud A. Aloribyb*, Marwa Tariq Ali Alsenousic, Hana M. Aljilalid
العدد: العدد الأول - SCIENTIFIC NATION JOURNAL VOL.0 ISSUE.1 . 2025 (المجلد 1، العدد 1)
Background: Antimicrobial resistance
is an escalating global health threat, complicating the treatment of bacterial
infections. The study aim to assess the in vitro antibiotic susceptibility of
clinically significant bacterial isolates—Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus—to commonly used
antibiotics in Benghazi, Libya, during 2025.
Methods: Standard disc diffusion techniques were employed to test seven
antibiotics (Rifampicin, Clindamycin, Levofloxacin, Meropenem, Ampicillin,
Gentamicin, and Tetracycline) against the three bacterial species. Sensitivity
and resistance profiles were analyzed to determine the most effective
therapeutic agents.
Results: Meropenem and Gentamicin exhibited the highest overall efficacy,
each achieving a sensitivity rate of 90.9%, followed by Levofloxacin (81.8%).
Ampicillin also demonstrated moderate sensitivity across isolates. Conversely,
high resistance rates were observed for Rifampicin (72.7%), Tetracycline
(72.7%), and Clindamycin, particularly among Gram-negative bacteria. Notably, S. aureus displayed greater overall
susceptibility compared to P. aeruginosa and E. coli.
Conclusion: Meropenem, Gentamicin, and Levofloxacin were the most effective antibiotics against the studied isolates. However, the substantial resistance to several first-line agents emphasizes the urgent need for antimicrobial stewardship and continuous local resistance monitoring. Developing antibiotic policies tailored to regional susceptibility patterns is crucial to optimize treatment outcomes and mitigate the spread of multidrug-resistant organisms.